← Back to Screener
COMPASS Pathways Plc American Depository Shares (CMPS)
Price$12.11
Momentum ScoreB
Favorite Metrics
Price vs S&P 500 (26W)110.27%
Price vs S&P 500 (4W)22.21%
VGM Score79.38
Market Capitalization$1.76B
All Metrics
Book Value / Share (Quarterly)$2.42
P/TBV (Annual)2.20x
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-1.18
Price vs S&P 500 (YTD)67.35%
EPS (TTM)$-2.00
10-Day Avg Trading Volume4.31M
EPS Excl Extra (TTM)$-2.00
EPS (Annual)$-3.08
ROI (Annual)-83.91%
Cash / Share (Quarterly)$3.45
ROA (Last FY)-136.85%
EBITD / Share (TTM)$-1.74
ROE (5Y Avg)-51.83%
Cash Flow / Share (Annual)$-1.64
P/B Ratio5.39x
P/B Ratio (Quarterly)2.18x
Net Income / Employee (Annual)$-1,845,300
Net Interest Coverage (TTM)-1.49x
ROA (TTM)-55.39%
EPS Incl Extra (Annual)$-3.08
Current Ratio (Annual)0.77x
Quick Ratio (Quarterly)3.18x
3-Month Avg Trading Volume4.10M
52-Week Price Return167.33%
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$4.09
52-Week High$14.76
EPS Excl Extra (Annual)$-3.08
26-Week Price Return118.20%
Quick Ratio (Annual)0.69x
13-Week Price Return78.75%
Total Debt / Equity (Annual)0.20x
Current Ratio (Quarterly)3.32x
Enterprise Value$1.35B
Revenue / Employee (Annual)$0
Cash / Share (Annual)$1.56
3-Month Return Std Dev115.33%
Net Income / Employee (TTM)$-1,146,100
ROE (Last FY)-100.28%
Net Interest Coverage (Annual)-0.68x
EPS Basic Excl Extra (Annual)$-3.08
Total Debt / Equity (Quarterly)0.15x
EPS Incl Extra (TTM)$-2.00
ROI (TTM)-39.84%
Revenue / Share (Annual)$0.00
Tangible BV / Share (Annual)$4.25
Price vs S&P 500 (52W)142.96%
Year-to-Date Return75.51%
5-Day Price Return-14.66%
EPS Normalized (Annual)$-3.08
ROA (5Y Avg)-64.52%
Month-to-Date Return-7.27%
Cash Flow / Share (TTM)$-2.58
EBITD / Share (Annual)$-1.91
LT Debt / Equity (Annual)0.16x
ROI (5Y Avg)-47.37%
LT Debt / Equity (Quarterly)0.15x
EPS Basic Excl Extra (TTM)$-2.00
P/TBV (Quarterly)1.58x
P/B Ratio (Annual)1.67x
Book Value / Share (Annual)$2.26
Price vs S&P 500 (13W)70.49%
Beta2.53x
Revenue / Share (TTM)$0.00
ROE (TTM)-48.36%
52-Week Low$2.25
mGradeB
vgmGradeB
Show chart for
Earnings Surprise History
Q1 26-0.30est. -0.39
Analyst Recommendations
Mar 2026
Apr 2026
May 2026
Jun 2026
4.18
4.17
4.15
4.23
Industry Peers — Pharmaceuticals(550)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
CMPSCOMPASS Pathways Plc American Depository Shares | — | — | B | $12.11 |
| LLYEli Lilly & Co. | D | B | B | $1131.42 |
| JNJJohnson & Johnson | D | C | B | $232.77 |
| ABBVABBVIE INC. | D | C | C | $227.23 |
| MRKMerck & Co., Inc. | C | C | B | $120.79 |
| NVSNovartis AG | C | C | C | $149.16 |
| AZNAstraZeneca PLC | D | B | C | $185.95 |
| NVONovo-Nordisk A/S | B | B | B | $42.96 |
| ABTAbbott Laboratories | C | C | D | $91.07 |
| PFEPfizer Inc. | B | C | C | $26.04 |
| BMYBristol-Myers Squibb Co. | B | C | B | $57.27 |
About
Compass Pathways is a mental health company developing psilocybin-based therapies for treatment-resistant depression (TRD), a severe form of major depressive disorder with limited existing treatment options. The company's approach combines its proprietary high-purity psilocybin formulation (COMP360) with psychological support to create a comprehensive treatment model. By targeting an underserved patient population, Compass addresses a significant unmet medical need in mental health care.